AGO2 and cancer: MiRNA dysregulations in human cancer are mainly due to genomic changes including amplification, mutation, deletion, and disturbance of miRNA biogenesis enzymes, namely, Drosha, exportin 5, Dicer, and argonaute 2 (ARO2), and effects of these changes show cell/organ specificity [36–38].